Compugen Narrows Loss, Posts $90K in Revenues in Q4 | GenomeWeb
NEW YORK (GenomeWeb News) – Compugen said today that it narrowed its fourth-quarter net loss to $3.1 million from $3.8 million in the fourth quarter of 2006. 
 
The company reported $90,000 in revenues for the quarter ended Dec. 31, 2007, compared to $10,000 for the fourth quarter of 2006. Revenues for both periods are from “small initial milestone payments under earlier agreements,” Compugen said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.